Zheng, et al.. Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of Hnf4α. no. 9, Ivyspring International Publisher, Apr. 2019, doi:10.7150/thno.32344.